Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1804 1
1827 1
1853 1
1861 1
1881 1
1889 1
1895 1
1907 1
1909 1
1917 1
1918 1
1921 1
1925 1
1927 1
1931 4
1932 2
1933 2
1934 2
1935 2
1936 1
1937 4
1938 1
1939 2
1941 5
1942 2
1944 3
1945 30
1946 51
1947 31
1948 35
1949 30
1950 62
1951 66
1952 78
1953 79
1954 92
1955 67
1956 74
1957 62
1958 62
1959 58
1960 54
1961 46
1962 58
1963 50
1964 57
1965 38
1966 41
1967 37
1968 41
1969 41
1970 59
1971 53
1972 51
1973 37
1974 44
1975 52
1976 80
1977 79
1978 100
1979 84
1980 88
1981 105
1982 78
1983 86
1984 99
1985 112
1986 117
1987 239
1988 383
1989 420
1990 439
1991 450
1992 498
1993 566
1994 531
1995 643
1996 637
1997 583
1998 547
1999 555
2000 619
2001 613
2002 607
2003 619
2004 593
2005 708
2006 748
2007 798
2008 843
2009 1033
2010 1184
2011 1419
2012 1712
2013 1857
2014 2250
2015 2502
2016 3093
2017 4182
2018 5043
2019 6610
2020 10497
2021 14348
2022 14673
2023 15692
2024 16988
2025 14580
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120,000 results

Results by year

Filters applied: . Clear all
Page 1
Profile of Roche's cobas HCV tests.
Kessler HH, Stelzl E. Kessler HH, et al. Expert Rev Mol Diagn. 2017 Apr;17(4):311-319. doi: 10.1080/14737159.2017.1293526. Epub 2017 Feb 22. Expert Rev Mol Diagn. 2017. PMID: 28277143 Review.
Furthermore, the HCV genotype should be assessed prior to treatment initiation. Recently, Roche developed the cobas HCV tests for use on the cobas 6800/8800 Systems and the cobas 4800 System and the cobas HCV genotyping (GT) test for use on the cobas 4800 System. ...Expert …
Furthermore, the HCV genotype should be assessed prior to treatment initiation. Recently, Roche developed the cobas HCV tests for use …
The history of benzodiazepines.
Wick JY. Wick JY. Consult Pharm. 2013 Sep;28(9):538-48. doi: 10.4140/TCP.n.2013.538. Consult Pharm. 2013. PMID: 24007886
By 1960, Hoffmann-La Roche marketed it as Librium, and it pursued molecular modifications for enhanced activity. Valium (diazepam) followed in 1963. Hoffmann-La Roche's competitors also began looking for analogues. Initially, benzodiazepines appeared to be le …
By 1960, Hoffmann-La Roche marketed it as Librium, and it pursued molecular modifications for enhanced activity. Valium (diazepam) fo …
Jaundice in the adult patient.
Roche SP, Kobos R. Roche SP, et al. Am Fam Physician. 2004 Jan 15;69(2):299-304. Am Fam Physician. 2004. PMID: 14765767 Free article. Review.
Profile of Roche's Elecsys Troponin T Gen 5 STAT blood test (a high-sensitivity cardiac troponin assay) for diagnosing myocardial infarction in the emergency department.
Kavsak PA, Andruchow JE, McRae AD, Worster A. Kavsak PA, et al. Expert Rev Mol Diagn. 2018 Jun;18(6):481-489. doi: 10.1080/14737159.2018.1476141. Epub 2018 May 18. Expert Rev Mol Diagn. 2018. PMID: 29756512 Review.
The Elecsys Troponin T Gen 5 STAT test (distributed in the United States (US) by Roche Diagnostics, Indianapolis, IN) is the first high-sensitivity cardiac troponin test approved for use by the FDA in the US (2017). ...
The Elecsys Troponin T Gen 5 STAT test (distributed in the United States (US) by Roche Diagnostics, Indianapolis, IN) is the first hi …
RET Inhibitor Prompts Roche-Blueprint Alliance.
[No authors listed] [No authors listed] Cancer Discov. 2020 Sep;10(9):1246. doi: 10.1158/2159-8290.CD-NB2020-070. Epub 2020 Jul 23. Cancer Discov. 2020. PMID: 32703767
Blueprint Medicines entered into a strategic partnership with Roche to jointly develop and commercialize pralsetinib, a targeted agent for RET-driven malignancies. If pralsetinib is approved, Roche's vast commercial network and diagnostic abilities could help …
Blueprint Medicines entered into a strategic partnership with Roche to jointly develop and commercialize pralsetinib, a targeted agen …
Roche's immuno squeeze.
[No authors listed] [No authors listed] Nat Biotechnol. 2016 Jan;34(1):6. doi: 10.1038/nbt0116-6. Nat Biotechnol. 2016. PMID: 26744958 No abstract available.
Roche's cell squeeze provokes killers.
Osorio J. Osorio J. Nat Biotechnol. 2018 Dec 6;36(12):1129. doi: 10.1038/nbt1218-1129. Nat Biotechnol. 2018. PMID: 30520858 No abstract available.
Parallel worlds in pharma and academia.
Clevers H. Clevers H. Nat Med. 2025 May;31(5):1390. doi: 10.1038/s41591-025-03710-x. Nat Med. 2025. PMID: 40360846 No abstract available.
120,000 results
You have reached the last available page of results. Please see the User Guide for more information.